Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Point of Care (PoC) Molecular Diagnostics market in this environment.
In terms of revenue, this research report indicated that the global Point of Care (PoC) Molecular Diagnostics market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Point of Care (PoC) Molecular Diagnostics industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The ????Bayer Corporation aims at producing XX Point of Care (PoC) Molecular Diagnostics in 2020, with XX % production to take place in global market, ????Roche Diagnostics accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Point of Care (PoC) Molecular Diagnostics Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Point of Care (PoC) Molecular Diagnostics Market?
Bayer Corporation
Roche Diagnostics
Sysmex Corporation
Abaxis
Abbott Laboratories
BioMerieux SA
Bio-Rad Laboratories
Danaher Corporation
OraSure Technologies
...
Major Type of Point of Care (PoC) Molecular Diagnostics Covered in XYZResearch report:
Polymerase Chain Reaction (Real Time PCR)
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification
Others
Application Segments Covered in XYZResearch Market
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
For any other requirements, please feel free to contact us and we will provide you customized report.
Request Sample 
Request Discount 
Inquire Before BuyTable of Contents
Global Point of Care (PoC) Molecular Diagnostics Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Polymerase Chain Reaction (Real Time PCR) -Product Introduction and Major Manufacturers
1.1.2 In Situ Hybridization -Product Introduction and Major Manufacturers
1.1.3 Chips and Microarrays -Product Introduction and Major Manufacturers
1.1.4 Mass Spectrometry -Product Introduction and Major Manufacturers
1.1.5 Sequencing -Product Introduction and Major Manufacturers
1.1.6 Isothermal Amplification -Product Introduction and Major Manufacturers
1.1.7 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Point of Care (PoC) Molecular Diagnostics Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Point of Care (PoC) Molecular Diagnostics Market
3.1.1 Top Companies leading Point of Care (PoC) Molecular Diagnostics Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Point of Care (PoC) Molecular Diagnostics Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Point of Care (PoC) Molecular Diagnostics Market
3.2.1 Top Companies leading Point of Care (PoC) Molecular Diagnostics Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Point of Care (PoC) Molecular Diagnostics Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Point of Care (PoC) Molecular Diagnostics Market
3.3.1 Top Companies leading Point of Care (PoC) Molecular Diagnostics Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Point of Care (PoC) Molecular Diagnostics Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Point of Care (PoC) Molecular Diagnostics Market
3.4.1 Top Companies leading Point of Care (PoC) Molecular Diagnostics Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Point of Care (PoC) Molecular Diagnostics Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Point of Care (PoC) Molecular Diagnostics Market
3.5.1 Top Companies leading Point of Care (PoC) Molecular Diagnostics Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Point of Care (PoC) Molecular Diagnostics Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Point of Care (PoC) Molecular Diagnostics Market
3.6.1 Top Companies leading Point of Care (PoC) Molecular Diagnostics Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Point of Care (PoC) Molecular Diagnostics Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Point of Care (PoC) Molecular Diagnostics Market
3.7.1 Top Companies leading Point of Care (PoC) Molecular Diagnostics Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Point of Care (PoC) Molecular Diagnostics Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Point of Care (PoC) Molecular Diagnostics Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Point of Care (PoC) Molecular Diagnostics Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Point of Care (PoC) Molecular Diagnostics Sales and Growth Rate (2021-2026)
5.2 Global Point of Care (PoC) Molecular Diagnostics Sales Value and Growth Rate (2021-2026)
6 Point of Care (PoC) Molecular Diagnostics Competitive Analysis
6.1 Bayer Corporation
6.1.1 Bayer Corporation Company Profiles
6.1.2 Bayer Corporation Product Introduction
6.1.3 Bayer Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Roche Diagnostics
6.2.1 Roche Diagnostics Company Profiles
6.2.2 Roche Diagnostics Product Introduction
6.2.3 Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Sysmex Corporation
6.3.1 Sysmex Corporation Company Profiles
6.3.2 Sysmex Corporation Product Introduction
6.3.3 Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Abaxis
6.4.1 Abaxis Company Profiles
6.4.2 Abaxis Product Introduction
6.4.3 Abaxis Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Abbott Laboratories
6.5.1 Abbott Laboratories Company Profiles
6.5.2 Abbott Laboratories Product Introduction
6.5.3 Abbott Laboratories Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 BioMerieux SA
6.6.1 BioMerieux SA Company Profiles
6.6.2 BioMerieux SA Product Introduction
6.6.3 BioMerieux SA Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Bio-Rad Laboratories
6.7.1 Bio-Rad Laboratories Company Profiles
6.7.2 Bio-Rad Laboratories Product Introduction
6.7.3 Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Danaher Corporation
6.8.1 Danaher Corporation Company Profiles
6.8.2 Danaher Corporation Product Introduction
6.8.3 Danaher Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 OraSure Technologies
6.9.1 OraSure Technologies Company Profiles
6.9.2 OraSure Technologies Product Introduction
6.9.3 OraSure Technologies Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
7 Conclusion
| Price : US$ 3500 | Date : Dec 2025 |
| Category : Electronics | Pages : 206 |
| Price : US$ 3500 | Date : Dec 2025 |
| Category : Consumer Goods and Retail | Pages : 205 |
| Price : US$ 3500 | Date : Dec 2025 |
| Category : Telecom and IT | Pages : 213 |
| Price : US$ 3500 | Date : Nov 2025 |
| Category : Medical Devices | Pages : 190 |
| Price : US$ 3500 | Date : Nov 2025 |
| Category : Medical Devices | Pages : 210 |
We are happy to help! Call or write to us
